CrCest Study in Primary Mitochondrial Disease

Enrolling by invitation

Conditions studied: Mitochondrial Diseases

In brief

The purpose of this study is to perform a "muscle phenotyping" magnetic resonance imaging (MRI) assessment in patients receiving clinical care at the Children's Hospital of Philadelphia (CHOP) for mitochondrial disease that is either suspected (based on clinical presentation) or has a definite genetic diagnosis. The MRI assessment quantifies skeletal muscle oxidative phosphorylation (OXPHOS) capacity. Investigators hope that this study will contribute to our current knowledge of mitochondrial diseases and this study will help create a new diagnostic tool for use in both clinical care and in clinical trials.

Key facts

Study ID
NCT04734626
Run by
Children's Hospital of Philadelphia
People needed
230
Starts
2021-05-25
Expected to finish
2028-12-31
Last updated by the study team
2026-01-14

Who can join

Age: 7 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.